6. Parkinson disease Clinical trials / Disease details
Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05576818 (ClinicalTrials.gov) | June 30, 2022 | 10/10/2022 | Effect of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease | Clinical Study Evaluating the Efficacy and Safety of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease | Parkinson Disease | Drug: Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers | Tanta University | NULL | Recruiting | 45 Years | 65 Years | All | 66 | Phase 3 | Egypt |